Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02341664 · ClinicalTrials.gov registry record
Patient and Provider Assessment of Lipid Management Registry
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 7,658
- Enrollment target
NCT02341664: Completed study, sponsored by Duke University.
NCT02341664 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 7,658 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02341664 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 7,658 participants
- Enrollment target
Study Summary
The purpose of the Patient and Provider Assessment of Lipid Management Registry (PALM) is to gain a better understanding of physicians' cholesterol medication prescribing practices, patient and physician attitudes and beliefs related to cholesterol management, and current utilization of cholesterol-lowering therapies given the new ACC/AHA guideline recommendations. The PALM Registry hopes to allow for the design of ways to improve cholesterol management and decrease the burden of cardiovascular disease (CVD) in the US.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,658 participants |
| Start Date | 2015-05 |
| Est. Completion | 2016-02 |
What the finished NCT02341664 record still lists
NCT02341664 is an observational study that tracks outcomes without assigning an intervention. Its 7,658 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02341664 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02341664 about?
NCT02341664 is a clinical study titled "Patient and Provider Assessment of Lipid Management Registry". The purpose of the Patient and Provider Assessment of Lipid Management Registry (PALM) is to gain a better understanding of physicians' cholesterol medication prescribing practices, patient and physician attitudes and beliefs related to cholesterol management, and current utilization of cholesterol-...
What is the current status of trial NCT02341664?
This trial is currently completed. The enrollment target is 7,658 participants. The study started on 2015-05. Estimated completion is 2016-02.
Who is sponsoring clinical trial NCT02341664?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06560398 · 7,649 participants · NA
Working Through Outreach, Navigation and Digital Enabled Referral and Recruitment Strategies (ACT WONDER²S)
- NCT03848312 · 7,600 participants · Phase 3
Preventing Alzheimer's With Cognitive Training
- NCT00439049 · 7,500 participants
Substance Abuse Pre-Treatment Screening Study
- NCT04809740 · 7,500 participants · NA
Evaluating the Implementation and Impact of Navigator-delivered ePRO System
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia